ArticleAmerican journal of translational research2025
Enhanced recovery after surgery in the perioperative period promotes recovery of cervical cancer patients undergoing transabdominal radical resection.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of enhanced recovery after surgery-based perioperative nursing on postoperative pain and recovery in patients with cervical cancer: A retrospective cohort study.Experimental and therapeutic medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the effects of enhanced recovery after surgery (ERAS) during the perioperative period in patients undergoing transabdominal radical resection of cervical cancer.
methodsA total of 114 patients who underwent transabdominal radical resection for cervical cancer at the Red Cross Hospital of Yulin City from January 2020 to December 2023 were retrospectively reviewed. Patients were divided into two groups based on the perioperative intervention method: the ERAS group (n = 51) received ERAS-based management, while the control group (CG, n = 63) received conventional perioperative management. Key outcomes compared included postoperative recovery time, complication rates, hospital stay duration, T lymphocyte levels, and patient satisfaction.
resultsPostoperative anal exhaust time, first defecation time, ambulation time, and hospital stay were significantly shorter in the ERAS group compared to the CG group (all P < 0.05). The ERAS group also showed earlier catheter removal, faster bladder function recovery, and lower residual urine volume (all P < 0.05). Postoperative serum levels of C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) increased in both groups but were significantly lower in the ERAS group (all P < 0.05). The ERAS group demonstrated improved postoperative quality of life (QLQ-C30 scores), reduced Pittsburgh Sleep Quality Index (PSQI) and Self-Rating Anxiety Scale (SAS) scores, and a significantly lower incidence of postoperative urinary tract infection (7.84% vs. 30.16%, all P < 0.05). Treatment satisfaction was higher in the ERAS group (96.08% vs. 76.19%, P < 0.05).
conclusionERAS effectively promotes gastrointestinal function recovery, reduces hospital stay, accelerates postoperative rehabilitation, and enhances patient satisfaction in cervical cancer patients undergoing transabdominal radical resection. It is safe, economical, and has an efficient approach that supports wider clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.